98 related articles for article (PubMed ID: 14715241)
1. Vitamin K2 and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner.
Hiruma Y; Nakahama K; Fujita H; Morita I
Biochem Biophys Res Commun; 2004 Jan; 314(1):24-30. PubMed ID: 14715241
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain.
Hara K; Akiyama Y; Nakamura T; Murota S; Morita I
Bone; 1995 Feb; 16(2):179-84. PubMed ID: 7756045
[TBL] [Abstract][Full Text] [Related]
3. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors.
Taira H; Fujikawa Y; Kudo O; Itonaga I; Torisu T
Calcif Tissue Int; 2003 Jul; 73(1):78-85. PubMed ID: 14506958
[TBL] [Abstract][Full Text] [Related]
4. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.
Nakagawa N; Yasuda H; Yano K; Mochizuki Si; Kobayashi N; Fujimoto H; Shima N; Morinaga T; Chikazu D; Kawaguchi H; Higashio K
Biochem Biophys Res Commun; 1999 Nov; 265(1):158-63. PubMed ID: 10548507
[TBL] [Abstract][Full Text] [Related]
5. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
Koide M; Murase Y; Yamato K; Noguchi T; Okahashi N; Nishihara T
Biochem Biophys Res Commun; 1999 May; 259(1):97-102. PubMed ID: 10334922
[TBL] [Abstract][Full Text] [Related]
7. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M
Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
Tai H; Miyaura C; Pilbeam CC; Tamura T; Ohsugi Y; Koishihara Y; Kubodera N; Kawaguchi H; Raisz LG; Suda T
Endocrinology; 1997 Jun; 138(6):2372-9. PubMed ID: 9165025
[TBL] [Abstract][Full Text] [Related]
9. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
10. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.
Okada Y; Lorenzo JA; Freeman AM; Tomita M; Morham SG; Raisz LG; Pilbeam CC
J Clin Invest; 2000 Mar; 105(6):823-32. PubMed ID: 10727451
[TBL] [Abstract][Full Text] [Related]
12. The Natural Product 6-Gingerol Inhibits Inflammation-Associated Osteoclast Differentiation via Reduction of Prostaglandin E₂ Levels.
Hwang YH; Kim T; Kim R; Ha H
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30013004
[TBL] [Abstract][Full Text] [Related]
13. Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression.
Hwang YH; Kim T; Kim R; Ha H
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004401
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 strongly inhibits human osteoclast formation.
Take I; Kobayashi Y; Yamamoto Y; Tsuboi H; Ochi T; Uematsu S; Okafuji N; Kurihara S; Udagawa N; Takahashi N
Endocrinology; 2005 Dec; 146(12):5204-14. PubMed ID: 16150915
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Kim JA; Ihn HJ; Park JY; Lim J; Hong JM; Kim SH; Kim SY; Shin HI; Park EK
Int Orthop; 2015 Jan; 39(1):173-82. PubMed ID: 25416122
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2.
Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Chihara K
J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines.
Ono K; Akatsu T; Murakami T; Kitamura R; Yamamoto M; Shinomiya N; Rokutanda M; Sasaki T; Amizuka N; Ozawa H; Nagata N; Kugai N
J Bone Miner Res; 2002 May; 17(5):774-81. PubMed ID: 12009007
[TBL] [Abstract][Full Text] [Related]
18. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
Lee SK; Kalinowski J; Jastrzebski S; Lorenzo JA
J Immunol; 2002 Sep; 169(5):2374-80. PubMed ID: 12193704
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles.
Wei X; Zhang X; Zuscik MJ; Drissi MH; Schwarz EM; O'Keefe RJ
J Bone Miner Res; 2005 Jul; 20(7):1136-48. PubMed ID: 15940366
[TBL] [Abstract][Full Text] [Related]
20. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
